These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 11840295)

  • 1. Establishment and comprehensive analysis of a new human transformed follicular lymphoma B cell line, Tat-1.
    Denyssevych T; Lestou VS; Knesevich S; Robichaud M; Salski C; Tan R; Gascoyne RD; Horsman DE; Mayer LD
    Leukemia; 2002 Feb; 16(2):276-83. PubMed ID: 11840295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of t(14;18) in Hodgkin's lymphoma associated with follicular lymphoma.
    Yoshida M; Ichikawa A; Miyoshi H; Takeuchi M; Kimura Y; Nino D; Ohshima K
    Pathol Int; 2012 Aug; 62(8):518-24. PubMed ID: 22827759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma without t(14;18) and with BCL-6 rearrangement: a lymphoma subtype with distinct pathological, molecular and clinical characteristics.
    Jardin F; Gaulard P; Buchonnet G; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Picquenot JM; Duval C; Parmentier F; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2309-17. PubMed ID: 12399977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 antisense oligonucleotides are effective against systemic but not central nervous system disease in severe combined immunodeficient mice bearing human t(14;18) follicular lymphoma.
    Mohammad R; Abubakr Y; Dan M; Aboukameel A; Chow C; Mohamed A; Hamdy N; Al-Katib A
    Clin Cancer Res; 2002 Apr; 8(4):1277-83. PubMed ID: 11948143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-6 p53 mutations in lymphomas carrying the bcl-2/Jh rearrangement.
    Bellido M; Capello D; Altés A; Estivill C; Gaidano G; Pujol R; Bordes R; Baiget M; Saglio G; Sierra J; Nomdedéu JF
    Haematologica; 2002 Sep; 87(9):908-17. PubMed ID: 12217802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivative (3)t(3;18)(q27;q21)t(18;16)(q21;?) involving the BCL2 and BCL6 genes in follicular lymphoma with t(3;14;18)(q27;q32;q21).
    Yamamoto K; Ono K; Katayama Y; Shimoyama M; Matsui T
    Cancer Genet Cytogenet; 2007 Nov; 179(1):69-75. PubMed ID: 17981218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformation from follicular lymphoma to high-grade B-cell lymphoma/leukemia with additional t(2;8)(p12;q24), with inverse expressions of c-MYC and BCL-2, and light-chain switch.
    Mannouji K; Tasaka T; Akiyama T; Irei I; Sano F; Matsuhashi Y; Wada H; Tohyama K; Sugihara T; Sadahira Y
    Pathol Int; 2009 Apr; 59(4):261-4. PubMed ID: 19351371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An additional segment at 1p36 derived from der(18)t(14;18) in patients with diffuse large B-cell lymphomas transformed from follicular lymphoma.
    Nomura K; Kanda-Akano Y; Shimizu D; Okuda T; Yoshida N; Matsumoto Y; Nishida K; Taki T; Yokota S; Horiike S; Taniwaki M
    Ann Hematol; 2005 Jul; 84(7):474-6. PubMed ID: 15700138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.
    Papajík T; Jedlicková K; Kriegová E; Jarosová M; Raida L; Faber E; Hubácek J; Vondráková J; Pikalová Z; Indrák K
    Neoplasma; 2001; 48(6):501-5. PubMed ID: 11949845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathogenesis of non-Hodgkin lymphoma: a clinical perspective.
    Gaidano G; Pastore C; Volpe G
    Haematologica; 1995; 80(5):454-72. PubMed ID: 8566891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of detecting strong bcl-2 protein expression with flow cytometry in follicular lymphoma].
    Kobayashi S; Motomura S; Kishi Y; Hashimoto C; Maruta A; Kodama F
    Rinsho Ketsueki; 2004 Jul; 45(7):530-8. PubMed ID: 15359912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological conversion of follicular lymphoma with structural alterations of t(14;18) and immunoglobin genes.
    Raghoebier S; Broos L; Kramer MH; van Krieken JH; Kluin-Nelemans JC; van Ommen GJ; Kluin P
    Leukemia; 1995 Oct; 9(10):1748-55. PubMed ID: 7564520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
    Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
    Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas.
    Knezevich S; Ludkovski O; Salski C; Lestou V; Chhanabhai M; Lam W; Klasa R; Connors JM; Dyer MJ; Gascoyne RD; Horsman DE
    Leukemia; 2005 Apr; 19(4):659-63. PubMed ID: 15716988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal evolution in t(14;18)-positive follicular lymphoma, evidence for multiple common pathways, and frequent parallel clonal evolution.
    d'Amore F; Chan E; Iqbal J; Geng H; Young K; Xiao L; Hess MM; Sanger WG; Smith L; Wiuf C; Hagberg O; Fu K; Chan WC; Dave BJ
    Clin Cancer Res; 2008 Nov; 14(22):7180-7. PubMed ID: 19010834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous presentation of follicular lymphomas.
    Franco R; Fernández-Vázquez A; Mollejo M; Cruz MA; Camacho FI; García JF; Navarrete M; Piris MA
    Mod Pathol; 2001 Sep; 14(9):913-9. PubMed ID: 11557789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.